Natus Net Receivables from 2010 to 2026

NM4 Stock  EUR 0.24  0.02  7.69%   
Natus Medical's Net Receivables is decreasing over the last several years with slightly volatile swings. Net Receivables is predicted to flatten to about 20.3 M. During the period from 2010 to 2026 Natus Medical Incorporated Net Receivables regressed destribution of quarterly values had coefficient of variationof  45.01 and r-value of (0.54). View All Fundamentals
 
Net Receivables  
First Reported
2016-12-31
Previous Quarter
18.4 M
Current Value
22.8 M
Quarterly Volatility
36.1 M
 
Covid
 
Interest Hikes
Check Natus Medical financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Natus Medical's main balance sheet or income statement drivers, such as Interest Expense of 9 M, Selling General Administrative of 181.6 M or Total Revenue of 321.4 M, as well as many indicators such as . Natus financial statements analysis is a perfect complement when working with Natus Medical Valuation or Volatility modules.
  
This module can also supplement various Natus Medical Technical models . Check out the analysis of Natus Medical Correlation against competitors.
The Net Receivables trend for Natus Medical Incorporated offers valuable insights into the company's financial trajectory and strategic direction. By examining multi-year patterns, investors can identify whether Natus Medical is strengthening or weakening its position, and how this metric correlates with broader market conditions and industry benchmarks.

Latest Natus Medical's Net Receivables Growth Pattern

Below is the plot of the Net Receivables of Natus Medical Incorporated over the last few years. It is Natus Medical's Net Receivables historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Natus Medical's overall financial position and show how it may be relating to other accounts over time.
Net Receivables10 Years Trend
Slightly volatile
   Net Receivables   
       Timeline  

Natus Net Receivables Regression Statistics

Arithmetic Mean78,208,327
Geometric Mean67,777,089
Coefficient Of Variation45.01
Mean Deviation27,439,421
Median82,277,000
Standard Deviation35,200,802
Sample Variance1239.1T
Range106.7M
R-Value(0.54)
Mean Square Error929.1T
R-Squared0.30
Significance0.02
Slope(3,799,023)
Total Sum of Squares19825.5T

Natus Net Receivables History

202620.3 M
202521.4 M
202423.8 M
202354 M
202238.3 M
2021111.8 M
202093.1 M

About Natus Medical Financial Statements

Natus Medical stakeholders use historical fundamental indicators, such as Natus Medical's Net Receivables, to determine how well the company is positioned to perform in the future. Although Natus Medical investors may analyze each financial statement separately, they are all interrelated. For example, changes in Natus Medical's assets and liabilities are reflected in the revenues and expenses on Natus Medical's income statement, which ultimately affect the company's gains or losses. Understanding these patterns can help in making the right long-term investment decisions in Natus Medical Incorporated. Please read more on our technical analysis and fundamental analysis pages.
Last ReportedProjected for Next Year
Net Receivables21.4 M20.3 M

Currently Active Assets on Macroaxis

Other Information on Investing in Natus Stock

Natus Medical financial ratios help investors to determine whether Natus Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Natus with respect to the benefits of owning Natus Medical security.